Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (4): 55-61.doi: 10.6040/j.issn.1671-7554.0.2021.0472
XU Ge1, LI Qing1, ZHANG Cancan2, TIAN Yongjie1
CLC Number:
[1] Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach [J]. Hum Reprod Update, 2020, 26(3): 392-411. [2] Munro MG. Classification and reporting systems for adenomyosis [J]. J Minim Invasive Gynecol, 2020, 27(2): 296-308. [3] Bourdon M, Santulli P, Oliveira J, et al. Focal adenomyosis is associated with primary infertility [J]. Fertil Steril, 2020, 114(6): 1271-1277. [4] Horton J, Sterrenburg M, Lane S, et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis [J]. Hum Reprod Update, 2019, 25(5): 592-632. [5] Munro MG, Critchley HO, broder MS, et al. FIGO classification system(PALM-COEIN)for causes of abnormal uterine bleeding in nongravid women of reproductive age [J]. Int J Gynaecol Obstet, 2011, 113(1): 3-13. [6] Harrision D, Gravells P, Thompson R, et al. Poly(ADP-Ribose)glycohydrolase(PARG)vs. poly(ADP-Ribose)polymerase(PARP)- function in genome maintenance and relevance of inhibitors for anti-cancer therapy [J]. Front Mol Biosci, 2020, 7: 191. doi: 10.3389/fmolb.2020.00191. [7] Alemasova EE, Lavrik OI. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins [J]. Nucleic Acids Res, 2019, 47(8): 3811-3827. [8] 林雪艳, 李春艳, 侯小满, 等. PARP-1及EMT标志物在子宫腺肌病在位及异位内膜中的表达 [J]. 山东大学学报(医学版), 2017, 55(9): 36-40. LIN Xueyan, LI Chunyan, HOU Xiaoman, et al. Expressions of PARP-1 and EMT markers in eutopic and ectopic endometrium of adenomyosis [J]. Journal of Shandong University(Health Sciences), 2017, 55(9): 36-40. [9] Prieto-Garcia E, Diaz-Garcia CV, Garcia-Ruiz I, et al. Epithelial-to-mesenchymal transition in tumor progression [J]. Med Oncol, 2017, 34(7): 122. doi: 10.1016/j.yexcr.2021.112791. [10] Kang S, Zhao J, Liu Q, et al. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis [J]. Environ Mol Mutagen, 2009, 50(5): 361-366. [11] Knight M, Stanley S. HIF-1alpha as a central mediator of cellular resistance to intracellular pathogens [J]. Curr Opin Immunol, 2019, 60(10): 111-116. [12] Zhang FJ, Luo W, Lei GH. Role of HIF-1alpha and HIF-2alpha in osteoarthritis [J]. Joint Bone Spine, 2015, 82(3): 144-147. [13] 薛源, 林雪艳, 徐歌, 等. 低氧诱导因子-1α在子宫内膜异位症患者血清中的表达和对在位子宫内膜间质细胞上皮-间质转化的影响 [J]. 山东大学学报(医学版), 2021, 59(2): 41-47. XUE Yuan, LIN Xueyan, XU Ge, et al. Expression of hypoxia-inducible factor-1α in the serum of patients with endometriosis and its effect on epithelial mesenchymal transition of eutopic endometrial stromal cells [J]. Journal of Shandong University(Health Sciences), 2021, 59(2): 41-47. [14] Struble J, Reid S, Bedaiwy M. Adenomyosis: a clinical review of a challenging gynecologic condition [J]. J Minim Invasive Gynecol, 2016, 23(2): 164-185. [15] Chen D, Qiao H, Wang Y, et al. Adenomyosis-derived extracellular vesicles endow endometrial epithelial cells with an invasive phenotype through epithelial-mesenchymal transition [J]. Genes Dis, 2020, 7(4): 636-648. [16] Chen YJ, Li HY, Huang CH, et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis [J]. J Pathol, 2010, 222(3): 261-270. [17] Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair [J]. Arch Gynecol Obstet, 2009, 280(4): 529-538. [18] Krishnakumar R, Kraus WL. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets [J]. Mol Cell, 2010, 39(1): 8-24. [19] Kumar M, Jaiswal RK, Yadava PK, et al. An assessment of poly(ADP-ribose)polymerase-1 role in normal and cancer cells [J]. Biofactors, 2020, 46(6): 894-905. [20] Kaufman B, Shapira-Frommer R, Schmutzler RK, et al. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation [J]. J Clin Oncol, 2015, 33(3): 244-250. [21] Stark TW, Hensley PJ, Spwar A, et al. Predictive value of epithelial-mesenchymal-transition(EMT)signature and PARP-1 in prostate cancer radioresistance [J]. Prostate, 2017, 77(16): 1583-1591. [22] Liu Y, Zhang Y, Zhao Y, et al. High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer [J]. Oncol Lett, 2016, 12(5): 3825-3835. [23] Guo S, Zhang D, Lu X, et al. Hypoxia and its possible relationship with endometrial receptivity in adenomyosis: a preliminary study [J]. Reprod Biol Endocrinol, 2021, 19(1): 7. doi:10.1186/s12958-020-00692-y. [24] Martínez-Romero R, Martínez-Lara E, Aguilar-Quesada R, et al. PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress [J]. J Cell Biochem, 2008, 104(6):2248-2260. [25] Gonzalez-Flores A, Aguilar-Quesada R, Siles E, et al. Interaction between PARP-1 and HIF-2α in the hypoxic response [J]. Oncogene, 2014, 33(7): 891-898. [26] Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von hippel-lindau ubiquitylation complex by O2-regulated prolyl hydroxylation [J]. Science, 2001, 292(5516): 468-472. [27] Buyn Y, Choi YC, Jeong Y, et al. MiR-200c downregulates HIF-1alpha and inhibits migration of lung cancer cells [J]. Cell Mol Biol Lett, 2019, 24: 28. doi:10.1186/s11658-019-0152-2. |
[1] | LIN Xueyan, ZHANG Cancan, TIAN Minle, TIAN Yongjie. Expression and significance of poly(ADP-ribose) polymerase-1 in endometriosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 27-31. |
[2] | GENG Chen, YANG Yang, ZHAO Yue, LIU Haoran, CHAO Lan. Identification of differentially expressed genes and Wilms tumor-1 expression in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 79-86. |
[3] | XUE Yuan, LIN Xueyan, XU Ge, TIAN Yongjie. Expression of hypoxia-inducible factor-1α in the serum of patients with endometriosis and its effect on epithelial mesenchymal transition of eutopic endometrial stromal cells [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 41-47. |
[4] | LIN Xueyan, LI Chunyan, HOU Xiaoman, TIAN Yongjie. Expressions of PARP-1 and EMT markers in eutopic and ectopic endometrium of adenomyosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 36-40. |
[5] | WU Lukanxuan, ZHU Shan, YU Jinxi, LÜ Chunzi, LI Mingjiang. Expression and significance of programmed death-1 and its ligand PD-L1 in adenomyosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 90-96. |
[6] | FAN Shaohua, ZHANG Yichao, YUAN Xiaodong, BI Jingwen, ZHANG Yichen, LI Yun. Expressions of MiR210 and stat3 following global ischemia in rats and the potential relationship among MiR210, stat3 and HIF-1α [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 1-5. |
[7] | CHEN Jianhua, ZHU Banghao. Inhibiting Effect of ginsenoside Re on the expression of PARP-1 in human umbilical vein endothelial cell [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 34-38. |
[8] | LIU Jing, ZHANG Hui, YAN Lei, ZHAO Xing-bo, LI Ming-jiang. Expression and significance of RhoE/Rnd3 protein in adenomyosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 116-. |
[9] | ZHANG Jing-jing1, WANG Zhe1, TIAN Yong-jie1, ZHANG Jie2. Effects of PJ34 on growth activity and cisplatin resistance of ovarian cancer C13* cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 46-50. |
[10] | . Expressions of PTEN and Akt and relationship to adenomyosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(10): 86-90. |
|